LJLaísa Simakawa Jimenez

Laísa Simakawa Jimenez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Laísa Simakawa Jimenez has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Inferior vena cava injuries: Are we doing what we really must?

    by Rodrigo Barros De Carvalho, Laisa Simakawa Jimenez, Renato Nardi Pedro, Vitor Favali Kruger, Mario Eduardo De Faria Mantovani, Thiago Rodrigues Araújo Calderan, Gustavo Pereira Fraga

    Objective: The inferior vena cava (IVC) is one of the most frequent injured intra-abdominal vessels and its treatment requires prompt action. Despite advances in reanimation in last decades, there has not been proportional improvement in IVC mortality. This report aims to discuss the mortality predictive factors including the adherence to balanced reanimation and damage control surgery (DCS) in daily trauma assistance, their repercussions on outcomes, comparing our institution outcomes to literature. Material and Methods: A retrospective design analysis was made through database records of trauma patients at Clinic Hospital of University of Campinas, UNICAMP in order to investigate patients with IVC injuries, putting an emphasis on mortality predictive factors. Results: Seventy-four patients were identified with IVC injury from January 1990 to August 2017. Predominant mechanism was penetrating with 87.8% (76.3% gunshot). On arrival, 37.8% of all of the victims were hypotensive, and ISS median was 24.5. Regarding location of IVC, 68.5% were infrarenal, 12.2% were suprarenal, 18.9% retrohepatic. Simple repair was performed in 60.8%. Ligation was carried out in 27% and atriocaval shunt was performed in 4.1%. There was not enough time for specific procedure in 8.1%. Associated intra-abdominal injuries were present in 97.3%, and the mean of transfusional requirements was 9.1 ± 6.9 for packed red blood cells. Overall mortality rate was 52.7%, with a mortality rate for infrarenal injuries being 39.2%. Damage control surgery was adopted in 33.8%, with 68% mortality. Conclusion: A solid comprehension of shock reanimation has progressively been disseminated; however, trauma care professionals must assure that they are being applied with balanced reanimation and DCS.


  • Open Access

    Trajectory of NAFLD characteristics after Roux-en-Y gastric bypass: a five-year historical cohort study

    by Fernanda Kreve, Guilherme Hoverter Callejas, Laísa Simakawa Jimenez, Rodolfo Araújo Marques, Felipe David Mendonça Chaim, Murillo Pimentel Utrini, Martinho Antonio Gestic, Almino Cardoso Ramos, Elinton Adami Chaim, Everton Cazzo

    BACKGROUND: The long-term effects of bariatric surgery on the course of non-alcoholic fatty hepatopa-thy (NAFLD) are not fully understood.OBJECTIVE: To analyze the evolution of NAFLD characteristics through noninvasive markers after Roux-en-Y gastric bypass (RYGB) over a five-year period.DESIGN AND SETTING: Historical cohort study; tertiary-level university hospital.METHODS: The evolution of NAFLD-related characteristics was evaluated among 49 individuals who un-derwent RYGB, with a five-year follow-up. Steatosis was evaluated through the hepatic steatosis index (HSI), steatohepatitis through the clinical score for non-alcoholic steatohepatitis (C-NASH) and fibrosis through the NAFLD fibrosis score (NFS).RESULTS: 91.8% of the individuals were female. The mean age was 38.3 +/- 10 years and average body mass index (BMI), 37.4 +/- 2.3 kg/m2. HSI significantly decreased from 47.15 +/- 4.27 to 36.03 +/- 3.72 at 12 months (P < 0.01), without other significant changes up to 60 months. C-NASH significantly decreased from 0.75 +/- 1.25 to 0.29 +/- 0.7 at 12 months (P < 0.01), without other significant changes up to 60 months. NFS de-creased from 1.14 +/- 1.23 to 0.27 +/- 0.99 at 12 months (P < 0.01), and then followed a slightly ascending course, with a marked increase by 60 months (0.82 +/- 0.89), but still lower than at baseline (P < 0.05). HSI variation strongly correlated with the five-year percentage total weight loss (R = 0.8; P < 0.0001).CONCLUSION: RYGB led to significant improvement of steatosis, steatohepatitis and fibrosis after five years. Fibrosis was the most refractory abnormality, with a slightly ascending trend after two years. Steato-sis improvement directly correlated with weight loss.


  • Open Access

    Effect of transient obstructive cholestasis on liver histology: a cross-sectional study

    by Thalita Mendes Mitsunaga, Laísa Simakawa Jimenez, Pedro França da Costa Soares, Martinho Antonio Gestic, Murillo Pimentel Utrini, Felipe David Mendonça Chaim, Francisco Callejas-Neto, Elinton Adami Chaim, Everton Cazzo

    The role of transient obstructive cholestasis on liver histology remains undetermined. To investigate whether transient cholestasis impairs liver histology. Cross-sectional study at a public university hospital (UNICAMP), Brazil. 169 individuals undergoing cholecystectomy, with or without cholestasis. were enrolled. Histopathological findings were correlated with clinical and biochemical characteristics. Biliary hepatopathy was more frequent in individuals with resolved cholestasis than in those with active obstruction or no jaundice (P < 0.01), as also were fibrosis and ductular proliferation (P = 0.02). Cholestasis was commoner in individuals with resolved obstruction than in those with no history (P < 0.01) or active cholestasis (P < 0.05). Biliary hepatopathy was associated with longer duration of cholestasis (P < 0.001) and higher bilirubin levels (P = 0.02) in individuals with active obstruction; with lower body mass index (P = 0.02) and longer cholestasis (P < 0.001) in individuals with resolved obstruction; and with longer cholestasis (P < 0.001) and longer interval between endoscopic retrograde cholangiopancreatography and surgery (P = 0.03) overall. In individuals with active obstruction, duration of cholestasis (R = 0.7; P < 0.001) and bilirubin levels (R = 0.6; P = 0.004) were independently correlated with cholestasis severity. Duration of cholestasis (R = 0.7; P < 0.001) was independently correlated with ductular proliferation severity. Transient cholestasis was associated with significant histopathological changes, even after its resolution. Longer duration of obstruction correlated with greater severity of histopathological changes, especially cholestasis and ductular proliferation. This emphasizes the need for early treatment of obstructive cholestasis.